Thompson TC - Search Results

1

Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancer.

Tahir SA, Yang G, Goltsov AA, Watanabe M, Tabata K, Addai J, Fattah el MA, Kadmon D, Thompson TC. Tahir SA, et al. Among authors: thompson tc. Cancer Res. 2008 Feb 1;68(3):731-9. doi: 10.1158/0008-5472.CAN-07-2668. Cancer Res. 2008. PMID: 18245473

2

Transforming growth factor beta 1 as a biomarker for prostate cancer.

Thompson TC, Truong LD, Timme TL, Kadmon D, McCune BK, Flanders KC, Scardino PT, Park SH. Thompson TC, et al. J Cell Biochem Suppl. 1992;16H:54-61. doi: 10.1002/jcb.240501212. J Cell Biochem Suppl. 1992. PMID: 1289674 Review.

3

Androgen sensitivity and gene expression in ras + myc-induced mouse prostate carcinomas.

Thompson TC, Egawa S, Kadmon D, Miller GJ, Timme TL, Scardino PT, Park SH. Thompson TC, et al. J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):79-85. doi: 10.1016/0960-0760(92)90190-t. J Steroid Biochem Mol Biol. 1992. PMID: 1525069

4

Alterations in mRNA levels for growth-related genes after transplantation into castrated hosts in oncogene-induced clonal mouse prostate carcinoma.

Egawa S, Kadmon D, Miller GJ, Scardino PT, Thompson TC. Egawa S, et al. Among authors: thompson tc. Mol Carcinog. 1992;5(1):52-61. doi: 10.1002/mc.2940050110. Mol Carcinog. 1992. PMID: 1543541

5

Experimental oncogene induced prostate cancer.

Thompson TC, Kadmon D, Timme TL, Merz VW, Egawa S, Krebs T, Scardino PT, Park SH. Thompson TC, et al. Cancer Surv. 1991;11:55-71. Cancer Surv. 1991. PMID: 1726789

6

Elevated plasma chromogranin-A concentrations in prostatic carcinoma.

Kadmon D, Thompson TC, Lynch GR, Scardino PT. Kadmon D, et al. Among authors: thompson tc. J Urol. 1991 Aug;146(2):358-61. doi: 10.1016/s0022-5347(17)37793-5. J Urol. 1991. PMID: 1856931

7

Elevated transforming growth factor-beta 1 and beta 3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progression.

Merz VW, Miller GJ, Krebs T, Timme TL, Kadmon D, Park SH, Egawa S, Scardino PT, Thompson TC. Merz VW, et al. Among authors: thompson tc. Mol Endocrinol. 1991 Apr;5(4):503-13. doi: 10.1210/mend-5-4-503. Mol Endocrinol. 1991. PMID: 1922083

8

Growth factors and oncogenes in prostate cancer.

Thompson TC. Thompson TC. Cancer Cells. 1990 Nov;2(11):345-54. Cancer Cells. 1990. PMID: 2282250 Review.

9

The frequency of apoptosis correlates with the prognosis of Gleason Grade 3 adenocarcinoma of the prostate.

Aihara M, Scardino PT, Truong LD, Wheeler TM, Goad JR, Yang G, Thompson TC. Aihara M, et al. Among authors: thompson tc. Cancer. 1995 Jan 15;75(2):522-9. doi: 10.1002/1097-0142(19950115)75:2<522::aid-cncr2820750215>3.0.co;2-w. Cancer. 1995. PMID: 7529128

10

Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer.

Thompson TC, Park SH, Timme TL, Ren C, Eastham JA, Donehower LA, Bradley A, Kadmon D, Yang G. Thompson TC, et al. Oncogene. 1995 Mar 2;10(5):869-79. Oncogene. 1995. PMID: 7534899

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262 results

Search Page

Filters